Skip to main content
Earnings Labs
MannKind Corporation logo

MannKind Corporation (MNKD)

NASDAQ·Healthcare·Biotechnology

$3.91

+2.76%

Mkt Cap $1.27B

Analyst Ratings

Buy

11

Hold

0

Sell

0

Price Target (12 analysts)

$8.50

Range $6.00$11.00

Implied Upside

+117.7%

Consensus $8.50 vs current $3.91